(Q44972579)

7 December 2017

title

Identification of adjuvants that enhance the therapeutic antibody response to host IgE. (English)

1 reference

7 December 2017

Jeannette Johansson

1

1 reference

7 December 2017

Anna Ledin

2

1 reference

7 December 2017

Molly Vernersson

3

1 reference

7 December 2017

Karin Lövgren-Bengtsson

4

1 reference

7 December 2017

Lars Hellman

5

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

7 December 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

7 December 2017

volume

22

1 reference

7 December 2017

issue

21-22

1 reference

7 December 2017

page(s)

2873-2880

1 reference

PROPHYLACTIC INOCULATION AGAINST HAY FEVER

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.029

Profound reduction in allergen sensitivity following treatment with a novel allergy vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.029

Generation of therapeutic antibody responses against IgE through vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.029

Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.029

Adjuvants--a classification and review of their modes of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.029

Advances in vaccine adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.029

ISCOMs and other saponin based adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.029

Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.029

In vivo and in vitro lipidation of recombinant immunogens for direct iscom incorporation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.029

Monophosphoryl lipid A (MPL) formulations for the next generation of vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.029

Structure and evolution of the heavy chain from rat immunoglobulin E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.029

Evidence for an early appearance of modern post-switch isotypes in mammalian evolution; cloning of IgE, IgG and IgA from the marsupial Monodelphis domestica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.029

Vaccines for control of fertility and hormone-dependent cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.029

The HSD-hCG vaccine prevents pregnancy in women: feasibility study of a reversible safe contraceptive vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.12.029

10.1016/J.VACCINE.2003.12.029

7 January 2021

Identifiers

DOI

1 reference

7 December 2017

1 reference